Mineralys Therapeutics Inc
(NAS:MLYS)
$
30.4
-0.050 (-0.16%)
Market Cap: 2.68 Bil
Enterprise Value: 2.03 Bil
PE Ratio: 0
PB Ratio: 3.93
GF Score: 37/100 Mineralys Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Jun 09, 2026 / 06:40PM GMT
Release Date Price:
$24.18
(+7.47%)
Unidentified Participant
Now to grab a handle off the top Next stop shot down Leo put the money down a little road You pay one more job or get it One shot goes crazy One for the road.
All right, let's kick off our next session.
It is my pleasure to be to host Mineral and Therapeutics. Here with me, John Tongleton and Adam Levy, CEO and CFO of the company. Gentlemen, welcome.
Always a pleasure to be hosting you guys for these events.
I appreciate the weather looking good this year.
Looking at the district compared to the first time we hope that we're -- I mean, there was a hurricane that went through.
Jon Congleton
Mineralys Therapeutics Inc - President, Chief Executive Officer, Director
We were talking about that earlier, yeah.
Unidentified Participant;Jon Congleton
Mineralys Therapeutics Inc - President, Chief Executive Officer,
So before we -- I have a lot of questions to ask, but before we go through that, I'll turn it to you for opening remarks.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot